No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr20:23807400-23812200 |
Weak transcription |
ES-I3 Cell Line |
embryonic stem cell
|
2 |
chr20:23807400-23812200 |
Weak transcription |
hESC Derived CD56+ Mesoderm Cultured Cells |
ES cell derived
|
3 |
chr20:23807400-23812400 |
Weak transcription |
HUES6 Cell Line |
embryonic stem cell
|
4 |
chr20:23807800-23811000 |
Weak transcription |
Foreskin Fibroblast Primary Cells skin01 |
Skin
|
5 |
chr20:23807800-23811000 |
Weak transcription |
NHDF-Ad |
bronchial
|
6 |
chr20:23807800-23812400 |
Weak transcription |
Mesenchymal Stem Cell Derived Adipocyte Cultured Cells |
ES cell derived
|
7 |
chr20:23808000-23812200 |
Weak transcription |
Adipose Derived Mesenchymal Stem Cell Cultured Cells |
ES cell derived
|
8 |
chr20:23808000-23812400 |
Weak transcription |
hESC Derived CD184+ Endoderm Cultured Cells |
ES cell derived
|
9 |
chr20:23809000-23810000 |
Bivalent Enhancer |
Fetal Adrenal Gland |
Adrenal Gland
|
10 |
chr20:23809000-23812400 |
Weak transcription |
H1 BMP4 Derived Trophoblast Cultured Cells |
ES cell derived
|
11 |
chr20:23809600-23812200 |
Weak transcription |
H1 Derived Mesenchymal Stem Cells |
ES cell derived
|
12 |
chr20:23811000-23813800 |
Enhancers |
NHDF-Ad |
bronchial
|
13 |
chr20:23811000-23814000 |
Enhancers |
Foreskin Fibroblast Primary Cells skin01 |
Skin
|
14 |
chr20:23811200-23811400 |
Enhancers |
Foreskin Fibroblast Primary Cells skin02 |
Skin
|
15 |
chr20:23811600-23812800 |
Weak transcription |
Foreskin Fibroblast Primary Cells skin02 |
Skin
|
16 |
chr20:23812200-23812800 |
Enhancers |
ES-I3 Cell Line |
embryonic stem cell
|
17 |
chr20:23812200-23813000 |
Enhancers |
Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells |
embryonic stem cell
|
18 |
chr20:23812200-23813200 |
Enhancers |
IMR90 fetal lung fibroblasts Cell Line |
lung
|
19 |
chr20:23812200-23813600 |
Enhancers |
hESC Derived CD56+ Mesoderm Cultured Cells |
ES cell derived
|
20 |
chr20:23812200-23813600 |
Enhancers |
Adipose Derived Mesenchymal Stem Cell Cultured Cells |
ES cell derived
|
21 |
chr20:23812200-23814000 |
Enhancers |
H1 Derived Mesenchymal Stem Cells |
ES cell derived
|
22 |
chr20:23812400-23812600 |
Enhancers |
HUES6 Cell Line |
embryonic stem cell
|
23 |
chr20:23812400-23813000 |
Enhancers |
HUVEC |
blood vessel
|
24 |
chr20:23812400-23813200 |
Enhancers |
H1 BMP4 Derived Trophoblast Cultured Cells |
ES cell derived
|
25 |
chr20:23812400-23813200 |
Enhancers |
Mesenchymal Stem Cell Derived Adipocyte Cultured Cells |
ES cell derived
|
26 |
chr20:23812400-23813200 |
Enhancers |
Bone Marrow Derived Cultured Mesenchymal Stem Cells |
Bone marrow
|
27 |
chr20:23812400-23813200 |
Enhancers |
Osteobl |
bone
|
28 |
chr20:23812400-23814000 |
Enhancers |
Breast variant Human Mammary Epithelial Cells (vHMEC) |
Breast
|
29 |
chr20:23812400-23814600 |
Enhancers |
hESC Derived CD184+ Endoderm Cultured Cells |
ES cell derived
|
30 |
chr20:23812600-23813200 |
Weak transcription |
HUES6 Cell Line |
embryonic stem cell
|
31 |
chr20:23812800-23813800 |
Enhancers |
Foreskin Fibroblast Primary Cells skin02 |
Skin
|
32 |
chr20:23813200-23813400 |
Enhancers |
HUES6 Cell Line |
embryonic stem cell
|
33 |
chr20:23816200-23817400 |
Enhancers |
Fetal Thymus |
thymus
|
34 |
chr20:23816600-23816800 |
Bivalent Enhancer |
Primary T cells fromperipheralblood |
blood
|
35 |
chr20:23823600-23824000 |
Enhancers |
Fetal Thymus |
thymus
|
36 |
chr20:23832400-23832800 |
Enhancers |
HUES64 Cell Line |
embryonic stem cell
|
37 |
chr20:23832400-23832800 |
Enhancers |
iPS-18 Cell Line |
embryonic stem cell
|
38 |
chr20:23832600-23833000 |
Enhancers |
hESC Derived CD56+ Mesoderm Cultured Cells |
ES cell derived
|
39 |
chr20:23832600-23833000 |
Enhancers |
iPS-15b Cell Line |
embryonic stem cell
|
40 |
chr20:23832600-23833000 |
Enhancers |
Breast variant Human Mammary Epithelial Cells (vHMEC) |
Breast
|
41 |
chr20:23832800-23833000 |
Enhancers |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
42 |
chr20:23832800-23838200 |
Weak transcription |
HUES64 Cell Line |
embryonic stem cell
|
43 |
chr20:23832800-23838200 |
Weak transcription |
iPS-18 Cell Line |
embryonic stem cell
|
44 |
chr20:23833000-23838000 |
Weak transcription |
iPS-15b Cell Line |
embryonic stem cell
|
45 |
chr20:23833000-23846800 |
Weak transcription |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
46 |
chr20:23836400-23836800 |
Enhancers |
Primary hematopoietic stem cells short term culture |
blood
|
47 |
chr20:23836400-23837000 |
Enhancers |
Fetal Thymus |
thymus
|
48 |
chr20:23836400-23837200 |
Enhancers |
Foreskin Melanocyte Primary Cells skin01 |
Skin
|
49 |
chr20:23836600-23836800 |
Enhancers |
hESC Derived CD56+ Ectoderm Cultured Cells |
ES cell derived
|
50 |
chr20:23836800-23838000 |
Weak transcription |
hESC Derived CD56+ Ectoderm Cultured Cells |
ES cell derived
|